home.aspx
 
.

Webinars

NEXT GENERATION BIOPROCESS FACILITY DESIGN – A CASE STUDY FROM SAMSUNG BIOLOGICS
NEXT GENERATION BIOPROCESS FACILITY DESIGN – A CASE STUDY FROM SAMSUNG BIOLOGICS
October 26-26, 2020
A case study be presented describing initiatives and bioprocessing approaches to maximize capacity utilization within a new large scale (12x 15kL) drug substance biologics manufacturing facility at Samsung Biologics. Facility design, manufacturing and validation strategies utilizing two harvest and ...

Advances in AAV Vectors and Gene Therapy
ADVANCES IN AAV VECTORS AND GENE THERAPY
October 27-27, 2020
Since the first proof-of-concept human application in the early ’90s, the field of gene therapy has overcome major setbacks and entered an exciting stage of clinical translation and transformation. Much of the credit goes to the development of new vector platforms, in particular recombinant ad...

Ensuring Safety and Efficacy of Biotherapeutics Through In-Depth LC-MS Sequence Variant Analysis
ENSURING SAFETY AND EFFICACY OF BIOTHERAPEUTICS THROUGH IN-DEPTH LC-MS SEQUENCE VARIANT ANALYSIS
October 28-28, 2020
In this webinar, we will show you how to find and confirm sequence variants more easily using the right mass spectrometry tools. Sequence variants are unintended amino acid substitutions that occur during the production of biotherapeutics. They are considered impurities in drug substances and may af...

The Great Convergence: How Biology and Engineering Unite to Reshape our World
THE GREAT CONVERGENCE: HOW BIOLOGY AND ENGINEERING UNITE TO RESHAPE OUR WORLD
October 28-28, 2020
A century ago, innovations in physics came together with engineering to produce an astonishing array of new technologies: radios, telephones, televisions, planes, radar, nuclear power, computers, GPS systems, the Internet, and more. These technologies so reshaped our world that we now can’t co...

Advantage of Antibody-Based Selectivity in the Purification of Next-Generation Biologics
ADVANTAGE OF ANTIBODY-BASED SELECTIVITY IN THE PURIFICATION OF NEXT-GENERATION BIOLOGICS
October 29-29, 2020
Advances in biotherapeutics are generating an increasing range of complex molecules that present unique and often complex purification challenges. Affinity chromatography can serve as a platform solution for the purification of these challenging molecule modalities. An effective affinity resin can h...

Innovative Technology for Insights into Receptor Tyrosine Kinase Biology
INNOVATIVE TECHNOLOGY FOR INSIGHTS INTO RECEPTOR TYROSINE KINASE BIOLOGY
October 29-29, 2020
Receptor Tyrosine Kinases (RTKs) regulate many critical processes such as cell growth, differentiation, and survival through the recruitment of intracellular signaling molecules. Dysregulated RTK activity can affect many cellular functions, often culminating in cancer, making RTKs prime targets for ...

Intact and Subunit MAM Assays Accelerate the Development of Antibody-Drug Conjugates
INTACT AND SUBUNIT MAM ASSAYS ACCELERATE THE DEVELOPMENT OF ANTIBODY-DRUG CONJUGATES
November 03-03, 2020
Multi-attribute method (MAM) is usually based on a bottom-up approach, which relies on the enzymatic digestion of the protein into peptides prior to mass spectrometry (MS) analysis. Unfortunately, this processing can result in the loss of information about the whole molecule, such as the drug distri...

Rapid Development of Multitagged Cell Lines for Drug Discovery
RAPID DEVELOPMENT OF MULTITAGGED CELL LINES FOR DRUG DISCOVERY
November 03-03, 2020
The pharmaceutical industry relies heavily on the use of in-vitro mammalian cell culture systems for drug discovery. Through in-vitro cell studies, targeted effects such as efficacy and toxicity can be tested before expensive animal studies, to select compounds with a higher probability of success. ...

ANALYTICAL CHALLENGES FOR GENE THERAPY
ANALYTICAL CHALLENGES FOR GENE THERAPY
November 03-03, 2020
One of the biggest challenges for AAV gene therapy products is establishing an appropriate analytical strategy to support product manufacture, release, stability, comparability and characterization at different stages of development. This presentation will highlight some of the existing analytical c...

Biomanufacturing Assumes Central Role in Cell and Gene Therapies
BIOMANUFACTURING ASSUMES CENTRAL ROLE IN CELL AND GENE THERAPIES
November 04-04, 2020
Cell and gene therapy products represent some of the most exciting new drugs that biopharmaceutical companies are looking to bring to market. Based on recent clinical successes, an increasing number of cell and gene therapies are currently in clinical development. However, despite the tremendous amo...

INNOVATION IN BIOMANUFACTURING PLANTS
INNOVATION IN BIOMANUFACTURING PLANTS
November 10-10, 2020
Biopharmaceutical plants will look different in the future. Agility and flexibility for rapidly changing product portfolios, single-use technologies, continuous manufacturing, small batch manufacturing, personalised medicine manufacturing will not only change the face of a plant but will also requir...

SMART MACHINE LEARNING SOLUTION TO MASTER INDUSTRY 4.0 IN BIOPHARMA
SMART MACHINE LEARNING SOLUTION TO MASTER INDUSTRY 4.0 IN BIOPHARMA
November 11-11, 2020
In the biopharmaceutical industry the utilization of miniaturized and parallelized high throughput techniques, continuous bioprocessing and continuous data acquisition as well as the utilization of data- and knowledge-driven tools for process analysis, forecasting, monitoring, control and digital tw...

Bioprocess Selection and Economics: 5,000-L DynaDrive™ Bioreactor Shifting the Paradigm
BIOPROCESS SELECTION AND ECONOMICS: 5,000-L DYNADRIVE™ BIOREACTOR SHIFTING THE PARADIGM
November 12-12, 2020
Single-use technologies enable a flexibility and modularity effectively unattainable with more traditional stainless-steel technologies, particularly in upstream bioprocesses. Single-use bioreactors up to 2,000 L are employed largely in preclinical- and clinical-stage bioprocesses to leverage this f...

REAL TIME MONITORING OF BIOPROCESS AND BEYOND – A PROCESS ANALYTICAL PERSPECTIVE
REAL TIME MONITORING OF BIOPROCESS AND BEYOND – A PROCESS ANALYTICAL PERSPECTIVE
November 16-16, 2020
Significant attention and interest has been granted towards developing an analytical paradigm with unprecedented capabilities of real time monitoring of process in biopharmaceutical development space in the past decade. The core requirement for real-time analytics involves Process Analytical Technol...

Biotechnology Virtual 2020
BIOTECHNOLOGY VIRTUAL 2020
November 16-16, 2020
We welcome you join our webinar on Biotechnology Virtual 2020 during November 16-17, 2020. It provides a unique crossroads for a diverse community of researchers, developers, scientists and students from research areas of Biotechnology, Bioengineering, Genome and Molecule breeding to share their res...

International Webinar on Biotechnology and Bioengineering Biotechnology Virtual 2020
INTERNATIONAL WEBINAR ON BIOTECHNOLOGY AND BIOENGINEERING BIOTECHNOLOGY VIRTUAL 2020
November 17-17, 2020
We welcome you join our webinar on Biotechnology Virtual 2020 during November 16-17, 2020. It provides a unique crossroads for a diverse community of researchers, developers, scientists and students from research areas of Biotechnology, Bioengineering, Genome and Molecule breeding to share their res...

PROCESS DEVELOPMENT & MANUFACTURING TECHNOLOGIES FOR BIO-THERAPEUTICS AND VACCINES
PROCESS DEVELOPMENT & MANUFACTURING TECHNOLOGIES FOR BIO-THERAPEUTICS AND VACCINES
November 24-24, 2020
Process Development & Manufacturing Technologies for Bio-therapeutics and experience in the Biotechnology (Vaccines and Biologics) industry, globally.

NOVEL TECHNOLOGIES THAT AID THE DETECTION AND DIFFERENTIATION OF PROTEINACEOUS IMPURITIES IN BIOLOGIC DRUG SUBSTANCES AND DRUG PRODUCT
NOVEL TECHNOLOGIES THAT AID THE DETECTION AND DIFFERENTIATION OF PROTEINACEOUS IMPURITIES IN BIOLOGIC DRUG SUBSTANCES AND DRUG PRODUCT
November 30-30, 2020
The goal of this presentation is to share recent developments in analytical approaches to detect, quantify and differentiate impurities in biologics that are the result of protein-container, interaction and aggregation.

SPOTLIGHT

A case study be presented describing initiatives and bioprocessing approaches to maximize capacity utilization within a new large scale (12x 15kL) drug substance biologics manufacturing facility at Samsung Biologics. Facility design, manufacturing and validation strategies utilizing two harvest and